Daytrana recall — FDA D-1169-2022
Defective Delivery System: Customer complaints received for ripping patches and tight release/adhesive transfer.
Browse the newest complete recall records currently stored from FDA enforcement reports and NHTSA vehicle campaigns. “Latest” refers to the newest source-dated record in this database, not the timestamp of our last API check.
The newest recall records with useful source details are listed here.
Defective Delivery System: Customer complaints received for ripping patches and tight release/adhesive transfer.
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Microbial contamination of non-sterile product: FDA laboratory analysis found product to contain microbial contamination identified as Providencia rettgeri.
Southeast Toyota Distributors, LLC (SET) is recalling certain 2020-2022 4Runner vehicles equipped with 20-inch Black Gunner Wheels. The load carrying capacity modification labels are…
Subaru of America, Inc. (Subaru) is recalling certain 2022 Outback vehicles. The engine wiring harness may have been damaged, resulting in a loose electrical connection to the engine…
General Motors (GM) has decided that certain 2022 model year Chevrolet Silverado, and GMC Sierra vehicles equipped with an accessory sport bar. The accessory sport bar contains a…
Failed Tablet/Capsule Specification; oversized tablet found in a bottle
Lack of Assurance of Sterility: Manufacturing deviation which was reported due to a microbial excursion
Defective Container: Product may leak when squeezed or when not in an upright position determined to be due to defects in the bottle neck finish and insufficient tightening.
CGMP Deviations: lots made with same active pharmaceutical ingredient (API) as lots that were rejected due to manufacturing issues that could cause the product to be out of specification…
Defective Delivery System: Out of specification for release liner removal force results at the 3-month CRT stability timepoint.
Ford Motor Company (Ford) is recalling certain 2022 Bronco and Ranger vehicles. The windshield may not have been properly bonded to the vehicle, which could allow it to detach during a…
Nissan North America, Inc. (Nissan) is recalling certain 2020-2022 Frontier and Titan vehicles. The transmission parking pawl may not engage when the vehicle is shifted into park, which can…
Ford Motor Company (Ford) is recalling certain 2022 Lincoln Aviator and Ford Explorer vehicles. The engine rails may have been improperly heat-treated. As such, these vehicles fail to…
General Motors, LLC (GM) is recalling certain 2022 Cadillac XT5, XT6, and GMC Acadia All-Wheel Drive (AWD) vehicles. The fuel tank rollover valve may not provide a proper seal in the event…
cGMP deviations
Lack of assurance of sterility
CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.
Subpotent Drug: FDA analysis has revealed some bottles of these products were sub potent for ethanol.
Marketed Without An Unapproved NDA/ANDA: Product lot found to be tainted with undeclared diclofenac, an FDA approved nonsteroidal anti-inflammatory drug (NSAID) for the treatment of pain…
Lack of assurance of sterility
CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.
Lack of assurance of sterility
Browse recent months with enough recall history for useful comparison.